Zobrazeno 1 - 10
of 15
pro vyhledávání: '"NET - neuroendocrine tumors"'
Autor:
Marta Opalińska, Anna Sowa-Staszczak, Anna Grochowska, Helena Olearska, Alicja Hubalewska-Dydejczyk
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
IntroductionNeuroendocrine neoplasms including neuroendocrine tumors (NETs) are often diagnosed as primary disseminated or inoperable. In those cases, systemic extensive therapy is necessary, but radical treatment is unlikely. As described in the lit
Externí odkaz:
https://doaj.org/article/1254a0f6a8cc42f8becf30fad0bed1c7
Publikováno v:
VideoGIE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0289142ab1ece4f6ffd1b72514c6c84d
https://doi.org/10.1016/j.vgie.2020.03.004
https://doi.org/10.1016/j.vgie.2020.03.004
Autor:
Kalaji Manhal, Remue Christophe, Bachmann Radu, Leonard Daniel, Schoelinck Jeremy, Kartheuser Alex
Publikováno v:
International Journal of Surgery Case Reports
International journal of surgery case reports, Vol. 91, no.1, p. 106760 (2022)
International journal of surgery case reports, Vol. 91, no.1, p. 106760 (2022)
Introduction Neuroendocrine tumors (NETs) of the rectum are rare, with an estimated incidence of 0.1% of all colorectal cancers. However, it is crucial to diagnose NET, particularly in patients with ulcerative colitis, who seem to have a higher risk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cf24e481e4e5e5ac68253e3b2ad5745
https://pubmed.ncbi.nlm.nih.gov/35091352
https://pubmed.ncbi.nlm.nih.gov/35091352
Autor:
Anna Grochowska, Alicja Hubalewska-Dydejczyk, Helena Olearska, Marta Opalińska, Anna Sowa-Staszczak
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
IntroductionNeuroendocrine neoplasms including neuroendocrine tumors (NETs) are often diagnosed as primary disseminated or inoperable. In those cases, systemic extensive therapy is necessary, but radical treatment is unlikely. As described in the lit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca9bf466923de44d16fbdc8a135ac3f6
https://www.frontiersin.org/articles/10.3389/fonc.2021.687925/full
https://www.frontiersin.org/articles/10.3389/fonc.2021.687925/full
Autor:
Thorvardur R. Halfdanarson, Magnus Halland, Thomas M. O'Dorisio, Boris G. Naraev, Amy J. Purvis, Daniel M. Halperin
Publikováno v:
Pancreas
Neuroendocrine tumors (NETs) arise from enterochromaffin cells found in neuroendocrine tissues, with most occurring in the gastrointestinal tract. The global incidence of NETs has increased in the past 15 years, likely due to better diagnostic method
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4a30c2e4853e20bef5a22f54c87235d
http://europepmc.org/articles/PMC6867674
http://europepmc.org/articles/PMC6867674
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Nirav Thosani, Subhas Banerjee, Udayakumar Navaneethan, Rahul Pannala, Zachary L. Smith, Mansour A. Parsi, Adam Goodman, Michael A. Manfredi, John T. Maple, Shelby Sullivan
Publikováno v:
VideoGIE
The use of RFA as a treatment modality in gastrointestinal endoscopy is expanding. RFA is frequently used in combination with focal EMR for the treatment of dysplastic BE and as standalone therapy for flat BE. Its efficacy in the treatment of esophag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5256129ec3ed9bb0ee3199dfea2990d1
https://doi.org/10.1016/j.vgie.2017.06.002
https://doi.org/10.1016/j.vgie.2017.06.002
Publikováno v:
International Journal of Surgery Case Reports
Highlights • Neuroendocrine tumor metastasis to the brain is a rare entity that commonly originates from the lungs. • Neuroendocrine tumor grade 1, which is considered benign, can metastasize to the brain. • Neuroendocrine tumor can mimic other
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32bf92cec111ad88fe41a1a0a5d40eed
https://doi.org/10.1016/j.ijscr.2021.105855
https://doi.org/10.1016/j.ijscr.2021.105855
Autor:
Lombard-Bohas, Catherine, Yao, James C., Hobday, Timothy, Van Cutsem, Eric, Wolin, Edward M., Panneerselvam, Ashok, Stergiopoulos, Sotirios, Shah, Manisha H., Capdevila, Jaume, Pommier, Rodney
Publikováno v:
Pancreas
Objective The aim of this study was to evaluate efficacy and safety of everolimus in patients with pancreatic neuroendocrine tumors (pNET) by prior chemotherapy use in the RAD001 in Advanced Neuroendocrine Tumors, Third Trial (RADIANT-3). Methods Pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::10f54403889c5c6b7dcbf88193fecaeb
http://europepmc.org/articles/PMC4327560
http://europepmc.org/articles/PMC4327560
Autor:
Malik RB; Division of Endocrinology, Diabetes & Metabolism, Cedars-Sinai Medical Center, Los Angeles, California., Ben-Shlomo A; Division of Endocrinology, Diabetes & Metabolism, Cedars-Sinai Medical Center, Los Angeles, California.; Multidisciplinary Adrenal Program, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California.
Publikováno v:
AACE clinical case reports [AACE Clin Case Rep] 2022 Oct 10; Vol. 8 (6), pp. 267-270. Date of Electronic Publication: 2022 Oct 10 (Print Publication: 2022).